Assay method for quality control and stability studies of a new antimalarial agent (CDRI 99/411)()

CDRI compound no. 99/411 is a potent 1,2,4-trioxane antimalarial candidate drug under development at our Institute. An HPLC method for determination of CDRI 99/411 with its starting material and intermediates has been developed and validated for in process quality control and stability studies. The...

Descripción completa

Detalles Bibliográficos
Autores principales: Khandelwal, Kiran, Pachauri, Shakti Deep, Zaidi, Sofia, Dwivedi, Pankaj, Sharma, Ashok Kumar, Singh, Chandan, Dwivedi, Anil Kumar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Xi'an Jiaotong University 2013
Materias:
Special Issue: HPLC in pharmaceutical analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5761009/
https://www.ncbi.nlm.nih.gov/pubmed/29403836
http://dx.doi.org/10.1016/j.jpha.2013.04.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5761009/
https://www.ncbi.nlm.nih.gov/pubmed/29403836
http://dx.doi.org/10.1016/j.jpha.2013.04.003

Ejemplares similares